2025 Chronic Pain Research and Development Topical 
Cannabis Law Report
MAY 28, 2021
But there is a factor that could serve to speed up the process – scientific research. The company has taken its deep pharmaceutical background and focused on developing an advanced, patented, effective, and safe cannabinoid delivery technology called Invisicare®. CBD-infused topicals are expected to reach $4.5
The Joint Blog
NOVEMBER 21, 2022
Cannabis consumption is still a polarizing topic. Indeed, only in the United States, it is projected to hit $16 billion by 2025. There are many causes why addictions develop in susceptible people, including peer pressure, early exposure to an environment in which drugs are consumed, as well as childhood abuse or trauma.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 20, 2019
She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. xi] “Pharmaceutical Research and Manufacturers of America (PhRMA) spent $19.7 billion in 2016. billion in 2017.”
Cannabis Law Report
FEBRUARY 18, 2020
Essentially, the report pointed out that no significant research on the effects of marijuana had been conducted before, and the cannabis ban in the city existed without any scientific evidence to back it up. The Department of Health conducted a formal study on this topic in 2018. Current situation and fight for recreational use.
Cannabis Law Report
OCTOBER 17, 2019
Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. billion in 2025, according to Grandview Research. the form the finished product can take (edibles, topicals, etc.).
Expert insights. Personalized for you.
64 
Let's personalize your content